Safend the Security Choice for TKT; Biopharmaceutical Company to Secure PC Endpoints.PHILADELPHIA -- Safend, a leading endpoint security company, announced today that Transkaryotic Therapies, Inc. (TKT TKT Ticket TKT Transketolase TKT Twisted Kaiju Theater (web forum) TKT T Kang Taekwondo (New York) TKT Thin Kerf Technologies ), a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases, has chosen Safend's USB Port A USB socket on a computer or peripheral device into which a USB cable is plugged. See USB. Protector to ensure the integrity of their data and systems. "Securing intellectual property during the product development stage is critical for our customer's long term success," said Dor Skuler, Vice President of Business Development for Safend. "We're pleased that TKT recognizes the unique solutions Safend offers and share our vision of end point security. We look forward to a long and safe relationship." Safend's USB Port Protector shields desktops and laptops by protecting their wired and wireless communication ports and connections to external devices and networks, such as disks-on-key, iPods, PDAs, Smart Phones, wireless modems, etc. Safend's products complement network security by providing comprehensive all-around security policy enforcement while still allowing the use of modern data storage technologies. "Previously we were limited in our ability to control restricted USB USB in full Universal Serial Bus Type of serial bus that allows peripheral devices (disks, modems, printers, digitizers, data gloves, etc.) to be easily connected to a computer. devices without also affecting acceptable devices like USB mice and keyboards," said Bob Litterer, Information Security Manager for TKT. "Safend's USB Port Protector allows us to choose which general classes of USB devices will work on our network, and even allows us to permit or deny specific USB devices based on vendor or device model. This granularity of control is exactly what we were looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. in a solution. We can now offer our users access to a large range of devices while maintaining the security of our network and the confidentiality of our data." TKT has also joined Safend's design partner program. In this capacity, the company will be able to provide useful feedback and customer perspectives on Safend's future product designs, product performance and feature updates. "We hope to take advantage of the solutions Safend offers while providing them with the feedback necessary to refine and enhance their solutions," Litterer commented. ABOUT TKT, INC. Transkaryotic Therapies, Inc. (TKT) is a NASDAQ-traded biopharmaceutical company headquartered in Cambridge, Massachusetts This article is about the city of Cambridge in Massachusetts. For the English university town, see Cambridge, England. For other places, see Cambridge (disambiguation). Cambridge, Massachusetts is a city in the Greater Boston area of Massachusetts, United States. with operations in the United Kingdom, Canada, South America South America, fourth largest continent (1991 est. pop. 299,150,000), c.6,880,000 sq mi (17,819,000 sq km), the southern of the two continents of the Western Hemisphere. and Sweden. The company markets one product, Replagal(TM), for the treatment of Fabry disease in the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community and other countries, and is developing products for Hunter syndrome Hunter syndrome Mucopolysaccharidosis type II Molecular medicine An X-R inborn error of metabolism caused by a deficit of sulfoiduronate or iduronosulfate sulfatase Clinical Type A–early onset is associated with a large skull, coarse facial features, profound and Gaucher disease Gaucher Disease Definition Gaucher disease is a rare genetic disorder that results in accumulation of fatty molecules called cerebrosides. It can have serious effects on numerous body organs including the liver, spleen, bones and central nervous system. . For more information on TKT, Inc. visit www.tktx.com. ABOUT SAFEND Safend, headquartered in Tel Aviv, Israel with offices in Philadelphia, PA, is committed to providing the world's most comprehensive end-point security solutions for the enterprise. Led by seasoned executives and security experts, Safend enables organizations to maximize productivity in the evolving communications world, without sacrificing security. For more information on Safend and its products, visit www.safend.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion